Canon gains health IT entry via Median Technologies

Canon has entered into a partnership agreement with CT-centered imaging and monitoring tool developer Median Technologies.

To facilitate the partnership, Canon, an imaging and optical product company based in Tokyo, will acquire a 15 percent stake in Median Technologies, amounting to a total investment of approximately $12 million.

The capital tie-in with Valbonne, France-based Median Technologies will enable Canon to access Median’s computer-aided diagnosis/detection (CAD) platform and engage in joint development of new CAD functionality, Canon stated.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.